Article
Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer.
Breast cancer research and treatment - 1 Nov 2020
Sim Eun Ji, Ko Kwang-Pil, Ahn Choonghyun, Park Sang Min, Surh Young-Joon, An Seokyung, Kim Sung-Won, Lee Min-Hyuk, Lee Jong Won, Lee Jeong Eon, Kim Ku Sang, Yom Cha Kyong, Kim Hyun-Ah, Park Sue K
Abstract excerpt
PURPOSE: We investigated the association between isoflavone (ISF) intake and hereditary breast cancer (BC) risk, particularly by molecular subtype, in East-Asian BRCA1/2 mutation carriers and non-carriers at a high risk of hereditary breast cancer (i.e., family history of BC (FHBC) and early-onset BC [EOBC, age < 40 years]). METHODS: The association between ISF intake and BC risk by molecular subtypes was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.